Verition Fund Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,752
Closed -$15K 2526
2022
Q1
$15K Buy
+24,752
New +$13.5K ﹤0.01% 2630

Other funds holding DRTSW

Verition Fund Management's DRTSW Position: Q2 2022 in Review

Verition Fund Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2022, closing a stake of 24,752 shares — an estimated $15K sold.

Verition Fund Management first reported a position in DRTSW in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 37 funds tracked by Wall St. Rank hold DRTSW as of Q2 2022.

  • Verition Fund Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • Verition Fund Management sold 24,752 Alpha Tau Medical Warrant shares in Q2 2022, an estimated $15K.
  • Verition Fund Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 1 quarter.
  • Verition Fund Management's Alpha Tau Medical Warrant position peaked at $15K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2022.

Based on Verition Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.